ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 924,77
-0,75%
Dow Jones
37 903,29
0,23%
DAX
17 944,72
0,13%
Brent Oil
83,825
0,34%
Bitcoin
58 216,96
-0,04%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Maravai LifeSciences Holdings Inc (MRVI)

  7. Maravai LifeSciences Holdings Inc (MRVI) Actualités

MRVI Maravai LifeSciences Holdings Inc

8,42
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Maravai LifeSciences Holdings Inc MRVI NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 8,42 10:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
8,42
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202422:49BWTriLink BioTechnologies® et Lonza signent un contrat de..
30/4/202413:31BWTriLink BioTechnologies® and Lonza Enter into Non-exclusive..
18/4/202421:12BWTriLink BioTechnologies® annonce un nouveau site à San Diego..
18/4/202421:09BWTriLink BioTechnologies® kündigt neue Anlage in San Diego..
18/4/202413:36BWTriLink BioTechnologies® Announces New San Diego Facility..
10/4/202422:05GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
12/3/202421:15GLOBEMaravai LifeSciences Announces March 2024 Investor..
29/2/202423:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202422:08EDGAR2Form 8-K - Current report
22/2/202422:05GLOBEMaravai LifeSciences Reports Fourth Quarter and Full Year..
21/2/202414:00BWTriLink BioTechnologies® Solidifies IP Position with Awarded..
21/2/202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202414:30GLOBEDyadic and Cygnus Technologies Announce Partnership To..
08/2/202422:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29/1/202414:00GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
19/1/202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202400:15EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
16/11/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202314:15GLOBEMaravai LifeSciences Announces November 2023 Investor..
08/11/202323:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:11EDGAR2Form 8-K - Current report
07/11/202322:05GLOBEMaravai LifeSciences Reports Third Quarter 2023 Financial..
02/11/202311:47BWTriLink BioTechnologies® Expands Capabilities with Launch of..
17/10/202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202314:15GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
29/9/202314:15GLOBEMaravai LifeSciences Hosts 2023 Investor R&D Day
19/9/202315:31GLOBEMaravai LifeSciences Chief Innovation Officer Kate Broderick..
05/9/202322:15GLOBEMaravai LifeSciences to Host 2023 Investor R&D Day
23/8/202314:15GLOBECygnus Technologies Receives 2023 R&D 100 Award for MockV®..
22/8/202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202322:15GLOBEMaravai LifeSciences Announces August 2023 Investor..
08/8/202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202322:19EDGAR2Form 8-K - Current report
07/8/202322:05GLOBEMaravai LifeSciences Reports Second Quarter 2023 Financial..
27/7/202322:11EDGAR2Form 8-K - Current report
27/7/202322:05GLOBEMaravai LifeSciences Announces Completion of Planned CEO..
24/7/202322:05GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
20/7/202322:08EDGAR2Form 8-K - Current report
20/7/202322:05GLOBEMaravai LifeSciences Announces Appointment of New Director..
19/7/202322:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202314:00GLOBECongressman Scott Peters Tours Maravai’s RNA manufacturing..
24/5/202322:58BWトライリンク・バイオテクノロジーズ®が製造能力拡張を発表、mRNA製造施設が完成間近

Dernières Valeurs Consultées

NASDAQ
MRVI
Maravai LifeSciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés